Lazard Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,185
Closed -$260K 2532
2023
Q2
$260K Buy
6,185
+2,049
+50% +$82.8K ﹤0.01% 1270
2023
Q1
$147K Buy
4,136
+1,385
+50% +$50.3K ﹤0.01% 1396
2022
Q4
$100K Sell
2,751
-438
-14% -$17.3K ﹤0.01% 1536
2022
Q3
$150K Sell
3,189
-193
-6% -$12.5K ﹤0.01% 1339
2022
Q2
$242K Buy
3,382
+2,717
+409% +$199K ﹤0.01% 1231
2022
Q1
$53K Buy
+665
New +$56.3K ﹤0.01% 1716
2021
Q4
Sell
-20,520
Closed -$1.79M 2501
2021
Q3
$1.79M Buy
+20,520
New +$1.86M ﹤0.01% 929
2018
Q2
Sell
-32,700
Closed -$1.16M 1135
2018
Q1
$1.16M Sell
32,700
-650,907
-95% -$25.5M ﹤0.01% 698
2017
Q4
$29.8M Sell
683,607
-13,232
-2% -$618K 0.05% 242
2017
Q3
$36.4M Sell
696,839
-50,772
-7% -$2.83M 0.07% 200
2017
Q2
$43.7M Sell
747,611
-68,847
-8% -$3.58M 0.08% 163
2017
Q1
$37.4M Buy
816,458
+150,895
+23% +$7.51M 0.07% 188
2016
Q4
$35M Buy
+665,563
New +$32.2M 0.07% 189
2016
Q1
Sell
-5,200
Closed -$252K 1126
2015
Q4
$252K Sell
5,200
-14,500
-74% -$645K ﹤0.01% 790
2015
Q3
$788K Buy
+19,700
New +$860K ﹤0.01% 667

Other funds holding SYNH

Lazard Asset Management's SYNH Position: Q3 2023 in Review

Lazard Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 6,185 shares — an estimated $260K sold.

Lazard Asset Management first reported a position in SYNH in Q3 2015 and held it in 15 quarters. The position peaked at $43.7M in Q2 2017. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Lazard Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Lazard Asset Management sold 6,185 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $260K.
  • Lazard Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 15 quarters.
  • Lazard Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $43.7M in Q2 2017.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Lazard Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.